Tempus AI Surges 15% in Nasdaq Debut, Valued at $6.65 Billion
Tempus AI rose 15% in its Nasdaq debut, reaching a $6.65B valuation. The company uses AI to enhance medical test accuracy and treatment.
Tempus AI Surges 15% in Nasdaq Debut, Valued at $6.65 Billion Read More